Artículo | 2024 |
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
|
EClinicalMedicine |
Letter | 2024 |
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry
|
HAEMATOLOGICA |
Corrección | 2024 |
Erratum: Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey (Infection (2024) 52 3 (1125-1141))
|
INFECTION |
Artículo | 2024 |
Genital chronic graft-versus-host disease: an unmet need that requires trained gynecologists
|
CLIMACTERIC |
Artículo | 2024 |
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
|
INFECTION |
Artículo | 2024 |
Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients: final long-term analysis from a prospective multicenter Phase-II Trial
|
BONE MARROW TRANSPLANTATION |
Artículo | 2024 |
Real-World Experience with Isavuconazole in Allogeneic Stem Cell Transplantation in Spain
|
Transplantation and Cellular Therapy |
Artículo | 2024 |
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the epicovideha registry
|
HEMATOLOGICAL ONCOLOGY |
Artículo | 2024 |
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
|
LEUKEMIA & LYMPHOMA |
Artículo | 2024 |
Update on Cytomegalovirus Infection Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients. A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
|
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES |
Artículo | 2023 |
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
|
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES |
Artículo | 2023 |
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)
|
HAEMATOLOGICA |
Artículo | 2023 |
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
|
Blood Advances |
Artículo | 2023 |
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
|
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS |
Artículo | 2023 |
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
|
EClinicalMedicine |
Artículo | 2023 |
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients
|
BLOOD CANCER JOURNAL |
Artículo | 2023 |
Outcome of COVID-19 in allogeneic stem cell transplant recipients: results from the EPICOVIDEHA registry
|
FRONTIERS IN IMMUNOLOGY |
Artículo | 2023 |
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
|
THERAPEUTIC ADVANCES IN HEMATOLOGY |
Artículo | 2022 |
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
|
BLOOD |
Artículo | 2022 |
COVID-19 and CAR T cells: current challenges and future directions-a report from the EPICOVIDEHA survey by EHA-IDWP
|
Blood Advances |
Letter | 2022 |
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report
|
HemaSphere |
Artículo | 2022 |
Mesenchymal Stromal Cells for Treating Steroid-Resistant Acute and Chronic Graft Versus Host Disease: A Multicenter Compassionate Use Experience
|
STEM CELLS TRANSLATIONAL MEDICINE |
Artículo | 2022 |
SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group
|
AMERICAN JOURNAL OF HEMATOLOGY |
Artículo | 2022 |
SF3B1, RUNX1 and TP53 mutations significantly impact the outcome of patients with lower-risk myelodysplastic syndrome
|
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA |
Artículo | 2021 |
Allogeneic hematopoietic stem cell transplant recipients in Spain: human leukocyte antigen characteristics and diversity by high-resolution analysis
|
HLA |
Artículo | 2021 |
Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation: a multicenter study from the Spanish hematopoietic transplantation and cell therapy group
|
TRANSPLANT INFECTIOUS DISEASE |
Artículo | 2021 |
Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment
|
BONE MARROW TRANSPLANTATION |
Artículo | 2021 |
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
|
Journal of Hematology and Oncology |
Artículo | 2021 |
Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group
|
AMERICAN JOURNAL OF TRANSPLANTATION |
Artículo | 2021 |
Defibrotide in hematopoietic stem cell transplantation: a multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH)
|
EUROPEAN JOURNAL OF HAEMATOLOGY |
Artículo | 2021 |
Long-term impact of an educational antimicrobial stewardship program on management of patients with hematological diseases
|
Antibiotics |
Letter | 2021 |
T-cells immune response controls the high incidence of adenovirus infection in adult allogenic hematopoietic transplantation recipients
|
HAEMATOLOGICA |
Artículo | 2020 |
Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: study protocol for the prospective multicentre OptimBioma study
|
BMJ OPEN |
Artículo | 2020 |
Risk factors and outcome of COVID-19 in patients with hematological malignancies
|
EXPERIMENTAL HEMATOLGY & ONCOLOGY |
Artículo | 2020 |
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study
|
BONE MARROW TRANSPLANTATION |
Artículo | 2019 |
Allocation to Matched Related or Unrelated Donor Results in Similar Clinical Outcomes without Increased Risk of Failure to Proceed to Transplant among Patients with Acute Myeloid Leukemia: A Retrospective Analysis from the Time of Transplant Approval
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
Resumen congreso | 2019 |
Influence of basic parameters of hemostasis in the hemorrhagic profile of the chronic PTI
|
HAEMATOLOGICA |
Resumen congreso | 2019 |
Mucormycosis in oncohematological patients and recipients of hematopoietic progenitor transplantation. Experience of a center in fourteen years
|
HAEMATOLOGICA |
Resumen congreso | 2019 |
Mutational profile in patients with low-risk myelodysplastic syndrome at the time of progression to acute leukemia
|
HAEMATOLOGICA |
Resumen congreso | 2019 |
Safety and efficacy of the BCR inhibitors after allogeneic stem cell transplantation for CLL
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2019 |
Sequential cumulative effect on the alfa diversity of the intestinal microbiota of honey-binding conditions and active antibiotics against gram-negatives
|
HAEMATOLOGICA |
Artículo | 2019 |
Thrombopoietin receptor agonists for severe thrombocytopenia after allogeneic stem cell transplantation: experience of the Spanish group of hematopoietic stem cell transplant
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
Artículo | 2018 |
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms
|
Blood Advances |
Resumen congreso | 2018 |
European Myeloma Network phase I trial on RIC allogeneic transplantation: an optimized program for high risk relapsed myeloma patients
|
BONE MARROW TRANSPLANTATION |
Artículo | 2018 |
Evaluation of parameters related to the probability of leukemic progression in patients with lower-risk myelodysplastic syndrome
|
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA |
Resumen congreso | 2018 |
FOUR CASES OF MYELOID NEOPLASM RELATED TO THERAPEUTICS IN THE CONTEXT OF TREATMENT OF SARCOMAS IN FLABBY PARTS
|
HAEMATOLOGICA |
Resumen congreso | 2018 |
Hematopoietic Stem cell transplant in Aplastic anemia in patients older than 40 years: the experience of the Spanish Group of Hematopoietic Stem Cell Transplant (GETH)
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2018 |
IBRUTINIB - RELATED TOXICITY AND SUSPENSION OF TREATMENT
|
HAEMATOLOGICA |
Resumen congreso | 2018 |
Prognostic value of minimal residual disease before allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia
|
BLOOD |
Resumen congreso | 2018 |
PROGNOSTIC VALUE OF PRE-ALOTPH EMR IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA
|
HAEMATOLOGICA |
Resumen congreso | 2018 |
RATIO OF ABSOLUTE CIRCULATING LYMPHOCYTES/MONOCYTES AS A PROGNOSTIC FACTOR IN THE DLCL-B TO DIAGNOSIS
|
HAEMATOLOGICA |
Resumen congreso | 2018 |
RESULTS OF TREATMENT GUIDED BY PET/INTERMEDIATE TAC IN PATIENTS WITH DIAGNOSIS OF LYMPHOMA B DIFFUSE OF LARGE CELLS (LBDCG). EXPERIENCE OF A CENTER
|
HAEMATOLOGICA |
Resumen congreso | 2018 |
Thrombopoietin receptor agonists for severe thrombocytopenia after allogeneic stem cell transplantation: experience of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH)
|
BLOOD |
Resumen congreso | 2018 |
USE OF SORAFENIB IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA FLT3-ITD POSITIVE IN SITUATION OF RELAPSE OR REFRACTORINESS: RECENT EXPERIENCE OF A CENTER
|
HAEMATOLOGICA |
Resumen congreso | 2018 |
WHAT CAN WE CONCLUDE FROM RUXOLITINIB AFTER MORE THAN 5 YEARS OF EXPERIENCE WITH THE DRUG?
|
HAEMATOLOGICA |
Resumen congreso | 2017 |
A multicenter randomized clinical trial evaluating the safety and feasibility of the treatment of GVHD with allogenic mesenchymal stem cells (MSC) from adipose tissue
|
CYTOTHERAPY |
Artículo | 2017 |
Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study
|
CYTOTHERAPY |
Resumen congreso | 2017 |
ANAGRELIDE RESPONSE ACCORDING TO THE MOLECULAR PROFILE: SOMETHING TO CONCLUDE ON THE MECHANISM OF ACTION OF THE DRUG IN MYELOPROLIFERATIVE NEOPLASMS (MPN)?
|
HAEMATOLOGICA |
Resumen congreso | 2017 |
ANALYSIS OF PROGNOSTIC FACTORS IN PATIENTS WITH MYELODISPLASIC SYNDROME SUBJECTED TO ALOGENIC TRANSPLANT OF HEMATOPOYETIC PROGENITORS
|
HAEMATOLOGICA |
Resumen congreso | 2017 |
Analysis of the incidence and causes of admission in the icu in large cohort of adult patients subjected to hematopoyetic transplantation
|
HAEMATOLOGICA |
Resumen congreso | 2017 |
ASSESSING PROGNOSIS IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES. PARAMETERS RELATED TO THE PROBABILITY OF LEUKEMIC PROGRESSION
|
LEUKEMIA RESEARCH |
Artículo | 2017 |
Clinical efficacy of beta-lactam/beta-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR)
|
BMJ OPEN |
Resumen congreso | 2017 |
Description of Mutational Profile in Patients with Lower-Risk Myelodysplastic Syndromes at the Time of Leukemic Progression
|
BLOOD |
Resumen congreso | 2017 |
DISCONTINUING ANTIBACTERIAL THERAPY AFTER APYREXIA AND CLINICAL STABILITY REGARDLESS OF NEUTROPHIL COUNT IN FEBRIL NEUTROPENIA IS SAFE AND REDUCES EXPOSITION TO ANTIBIOTICS (HOWLONG RANDOMIZED TRIAL)
|
HAEMATOLOGICA |
Artículo | 2017 |
Efficacy of beta-Lactam/beta-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia
|
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
Resumen congreso | 2017 |
EUROPEAN MYELOMA NETWORK CLINICAL TRIAL PHASE I (ALLO-EMN) OF ALLOGENIC TRANSPLANTATION IN PATIENTS WITH HIGH RISK MULTIPLE MYELOMA (MM)
|
HAEMATOLOGICA |
Resumen congreso | 2017 |
Improvement of outcome after autologous stem cell transplantation by reduction of infections and SOS/VOD syndrome's related mortality: 28 years single-center experience
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2017 |
Is idiopathic myelofibrosis (MFI) with V617 JAK2 mutation is the same entity as secondary myelofibrosis (MFS) to evolution of mutated myeloproliferative neoplasm (MPN)?
|
HAEMATOLOGICA |
Artículo | 2017 |
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2017 |
MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS AND TRANSPLANT RECIPIENTS OF HEMATOPOIETIC PROGENITORS
|
HAEMATOLOGICA |
Resumen congreso | 2017 |
MULTICENTRIC STUDY ON THE USE OF RUXOLITINIB IN ACUTE AND REFRACTORY CHRONIC EICH IN ONE OR MORE TREATMENT LINES. RESULTS OF OUR EXPERIENCE
|
HAEMATOLOGICA |
Artículo | 2017 |
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial
|
LANCET HAEMATOLOGY |
Artículo | 2017 |
Posicionamiento y actitudes de manejo sobre la profilaxis antifúngica en el paciente hematológico (proyecto PROMIC)
|
Revista Española de Quimioterapia |
Resumen congreso | 2017 |
Prognostic evaluation in patients with low risk myelodysplastic syndrome parameters related to the probability of leukemic progression
|
HAEMATOLOGICA |
Resumen congreso | 2017 |
Similar Probabilities of Failure to Reach Transplantation and Transplant Outcomes after HLA-Identical Sibling or Unrelated Donor Transplant in Patients with Acute Myeloid Leukemia: A Single Institution Evaluation of a Donor Selection Algorithm
|
BLOOD |
Resumen congreso | 2017 |
THE 1RC STATUS AND THE NEW DIAGNOSIS ARE ASSOCIATED WITH BETTER LONG-TERM SURVIVAL IN ALLOTRANSPLANTED PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA
|
HAEMATOLOGICA |
Resumen congreso | 2017 |
THE COMBINED TREATMENT WITH AAS AND HEPARIN OF LOW MOLECULAR WEIGHT IS EFFECTIVE IN THE PREVENTION OF THROMBOSIS IN PREGNANT WOMEN WITH MYELOPROLIFERATIVE NEOPLASMS
|
HAEMATOLOGICA |
Artículo | 2017 |
The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome
|
LEUKEMIA & LYMPHOMA |
Resumen congreso | 2017 |
THE PROBABILITY OF CONCLUDING ALLOGENIC TRANSPLANTATION FROM ITS INDICATION IS SIMILAR TO HAVING OR NOT HAVING HISTOCOMPATIBLE SIBLING: SELECTION STRATEGY BASED ON THE PREFERENTIAL USE OF UNRELATED DONOR (ND) AS AN ALTERNATIVE SOURCE OF HAEMATOPOIETIC PROGENITORS (HP)
|
HAEMATOLOGICA |
Resumen congreso | 2017 |
TO SUSPEND THE EMPIRICAL ANTIMICROBIAL TREATMENT AFTER THREE DAYS OF APYREXIA IN HEMATOLOGICAL PATIENTS WITH FEBRILE NEUTROPENIA IS SAFE AND REDUCES UNNECESSARY EXPOSURE TO ANTIBIOTICS: FINAL RESULTS OF THE RANDOMIZED CLINICAL TRIAL HOW LONG
|
HAEMATOLOGICA |
Resumen congreso | 2016 |
A novel genetic and clinical predictive model for severe acute and chronic graft versus host disease after identical HLA-allogeneic stem-cell transplantation
|
BONE MARROW TRANSPLANTATION |
Letter | 2016 |
Differences in stem cell transplantation activity among regions in Spain: an economic explanation
|
BONE MARROW TRANSPLANTATION |
Artículo | 2016 |
Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Espanol de Trasplante Hematopoyetico
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
Letter | 2016 |
Pre-transplant diastolic but not systolic dysfunction has a negative prognostic impact after allogeneic stem cell transplantation
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2016 |
Survival and long-term complications of receptors of hematopoietic progenitor transplantation
|
HAEMATOLOGICA |
Resumen congreso | 2016 |
THE INCORPORATION OF COMORBIDITIES IN THE PROGNOSTICATION OF PATIENTS WITH LOWER-RISK MDS
|
HAEMATOLOGICA |
Resumen congreso | 2015 |
A new multiple single-nucleotide polymorphisms based predictive model for grades III to IV and extensive graft versus host disease after identical HLA-allogeneic stem-cell
|
BLOOD |
Resumen congreso | 2015 |
A new predictive model based on the genomic profile of polymorphisms in genes of cytokines allows to predict the incidence of post-transplant EICR allogeneic hematopoietic
|
HAEMATOLOGICA |
Artículo | 2015 |
Acute myeloid leukemia 7 years after aleukemic leukemia cutis
|
INTERNATIONAL JOURNAL OF DERMATOLOGY |
Resumen congreso | 2015 |
After admission to intensive care unit non-transplant patients with haematologic malignancies have better survival outcome than recipients of haematopoietic stem cell transplantation
|
HAEMATOLOGICA |
Artículo | 2015 |
Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party
|
LEUKEMIA |
Resumen congreso | 2015 |
Characteristics of oncohematological patients admitted in the intensive care unit (uci): comparision between the patients subjected to transplant of hematopoietic progenitors and non transplantation (no-tph)
|
HAEMATOLOGICA |
Artículo | 2015 |
Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2015 |
IMPLICATIONES OF THE ADVERSE KARYOTYPE IN PATIENTS WITH MYELODYSPPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA. EXPERIENCE OF A CENTRE
|
HAEMATOLOGICA |
Artículo | 2015 |
Intermediate doses of cytarabine plus granulocyte-colony-stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure
|
TRANSFUSION |
Artículo | 2015 |
Mortality of Oncohematological Patients Undergoing Hematopoietic Stem Cell Transplantation Admitted to the Intensive Care Unit
|
TRANSPLANTATION PROCEEDINGS |
Resumen congreso | 2015 |
MUCORMYCOSIS IN ONCOHAEMATOLOGICAL PATIENTS AND RECEPTORS OF TRASPLANTS OF HAEMOTOPOIETIC PROGENITORS. EXPERIENCE OF THE LAST 10 YEARS OF A SINGLE CENTRE
|
HAEMATOLOGICA |
Artículo | 2015 |
Overexpression of GYS1, MIF, and MYC Is Associated With Adverse Outcome and Poor Response to Azacitidine in Myelodysplastic Syndromes and Acute Myeloid Leukemia
|
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA |
Artículo | 2015 |
Productivity loss due to premature mortality caused by blood cancer: a study based on patients undergoing stem cell transplantation
|
GACETA SANITARIA |
Resumen congreso | 2015 |
PROGNOSTIC VALUE OF THE EVALUATION OF THE PRETRANSPLANT ALLOGENEIC CARDIAC FUNCTION
|
HAEMATOLOGICA |
Resumen congreso | 2015 |
Pronostic Value of Pretransplant Echocardiography in Allogeneic Hematopoietic Cell Transplantation
|
BLOOD |
Artículo | 2015 |
Role of 18F-FDG-PET/CT in the management of Burkitt lymphoma
|
EUROPEAN JOURNAL OF HAEMATOLOGY |
Artículo | 2015 |
Role of 18F-FDG-PET/CT in the management of marginal zone B cell lymphoma
|
HEMATOLOGICAL ONCOLOGY |
Resumen congreso | 2015 |
THE ADDITION OF COMORBIDITY ALLOWS A BETTER STRATIFICATION AND DEVELOPMENT OF A SPECIFIC PROGNOSTIC SCORE IN THE GROUP OF PATIENTS WITH MYELODYSPLASTIC SYNDROME OF LOW RISK BY IPSS
|
HAEMATOLOGICA |
Artículo | 2015 |
The Genotype of the Donor for the (GT)(n) Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation
|
PLOS ONE |
Resumen congreso | 2015 |
THE INVASIVE FUNGAL INFECTION IS A CLINICALLY RELEVANT CAUSE OF MORTALITY AND MORBIDITY IN PATIENTS WITH LYMPHOPROLIFERATIVE SYNDROMES
|
HAEMATOLOGICA |
Artículo | 2014 |
Antifungal Combination Therapy for Invasive Aspergillosis
|
CLINICAL INFECTIOUS DISEASES |
Resumen congreso | 2014 |
AZACITIDINE IMPROVES SURVIVAL IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES WITH 20-30% BONE MARROW BLASTS AND POOR-RISK CYTOGENETIC CATEGOR
|
HAEMATOLOGICA |
Resumen congreso | 2014 |
Donor and recipient genotypes for interleukin 1 gene single nucleotide polymorphisms (SNPs) allow anticipation of acute graft versus host disease after HLA-identical allogeneic stem cell transplantation (allo-SCT)
|
BLOOD |
Artículo | 2014 |
Fludarabine, cyclophosphamide and rituximab as first-line treatment in patients with newly diagnosed follicular lymphoma
|
EUROPEAN JOURNAL OF HAEMATOLOGY |
Artículo | 2014 |
Infección nosocomial asociada al catéter venoso central en pacientes con Trasplante de Progenitores Hematopoyéticos
|
Evidentia: Revista de enfermería basada en la evidencia |
Artículo | 2014 |
Intra-Arterial Bone Marrow Mononuclear Cell Transplantation Correlates With GM-CSF, PDGF-BB, and MMP-2 Serum Levels in Stroke Patients: Results From a Clinical Trial
|
Cell Transplantation |
Artículo | 2014 |
Mismatch on Glutathione S-Transferase T1 Increases the Risk of Graft-versus-Host Disease and Mortality after Allogeneic Stem Cell Transplantation
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
Artículo | 2014 |
Patterns of Infection in Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia Receiving Azacitidine as Salvage Therapy. Implications for Primary Antifungal Prophylaxis
|
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA |
Resumen congreso | 2014 |
Role of PET/CT Assesment before Autologous Stem Cell Transplantation in Relapsed or Refractory Lymphoma Patients
|
BLOOD |
Resumen congreso | 2014 |
Single nucleotide polymorphisms (SNPS) in interleukin 1A and 1B genes associate with patient susceptibility to complications after HLA-identical sibling allo-SCT.
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2014 |
SNPs in the promoter region of the IL17A gene allow anticipation of complications after sibling HLA-identical allogeneic stem cell transplantation (allo-SCT)
|
BONE MARROW TRANSPLANTATION |
Artículo | 2014 |
Timing of CMV-specific effector memory T cells predicts viral replication and survival after allogeneic hematopoietic stem cell transplantation
|
TRANSPLANT INTERNATIONAL |
Artículo | 2013 |
A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2013 |
Azacitidine Alone Or The Combination With Valproic Acid As a Bridge Therapy For Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes Before Transplantation
|
BLOOD |
Artículo | 2013 |
Clinical Prognostic Factors for Survival and Risk of Progression to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndromes With < 10% Marrow Blasts and Non-Unfavorable Cytogenetic Categories
|
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA |
Artículo | 2013 |
Cost-Effectiveness Analysis Comparing Two Approaches for Empirical Antifungal Therapy in Hematological Patients with Persistent Febrile Neutropenia
|
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
Resumen congreso | 2013 |
EARLY DETECTION OF SERUM GALACTOMANNAN ANTIGEN IN HEMATOLOGIC MALIGNANCIES: IMPACT OF A LABORATORY ASSAY IN ASPERGILLUS INFECTION MORTALITY RATE
|
HAEMATOLOGICA |
Resumen congreso | 2013 |
Fludarabine, Cyclophosphamide and Rituximab As First Line Treatment In Follicular Lymphoma
|
BLOOD |
Resumen congreso | 2013 |
GSTT1 mismatch constitutes a risk factor for acute and chronic hepatic GVHD and influences patient survival
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2013 |
Higher-risk myelodysplastic syndromes. Does the severity of cytopenias at diagnosis have any prognostic significance?
|
LEUKEMIA RESEARCH |
Artículo | 2013 |
Improvement over the years of long-term survival in high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy
|
TRANSPLANTATION PROCEEDINGS |
Artículo | 2013 |
Lenograstim compared to filgrastim for the mobilization of hematopoietic stem cells in healthy donors
|
TRANSFUSION |
Resumen congreso | 2013 |
Memory B Cells Display Changes In The Expression Pattern Of Genes Related To Cell Survival In Elderly Individuals
|
BLOOD |
Resumen congreso | 2013 |
Mobilization Scheme With Cytarabine In Poor Mobilizers Patients Diagnosed With Lymphoma
|
BLOOD |
Resumen congreso | 2013 |
Multivariable Time-Dependent Analysis Of The Impact Of 5 Azacitidine In Patients With Lower-Risk Myelodysplastic Syndrome and Unfavorable Specific Lower-Risk Score
|
BLOOD |
Resumen congreso | 2013 |
Myelomatous Plasma Cells Display An Intermediate Gene Expression Pattern Between a Normal Plasma Cell and a Memory B Cell
|
BLOOD |
Resumen congreso | 2013 |
Patterns of infection in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) receiving 5-azacitidine. Candidates for antifungal prophylaxis
|
LEUKEMIA RESEARCH |
Letter | 2013 |
Pentostatin plus cyclophosphamide and bexarotene is an effective and safe combination in patients with mycosis fungoides/sezary syndrome
|
BRITISH JOURNAL OF HAEMATOLOGY |
Artículo | 2013 |
To freeze or not to freeze peripheral blood stem cells prior to allogeneic transplantation from matched related donors
|
EUROPEAN JOURNAL OF HAEMATOLOGY |
Artículo | 2012 |
A constitutional variant in the transcription factor EP300 strongly influences the clinical outcome of patients submitted to allo-SCT
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2012 |
A gene variant in IRF3 impacts on the clinical outcome of Acute Myeloid Leukemia (AML) patients submitted to allogeneic Stem Cell Transplantation (allo-SCT)
|
BLOOD |
Resumen congreso | 2012 |
Clinical prognostic factors for myelodysplastic syndromes presenting non-unfavourable cytogenetic categories according to IPSS and the new cytogenetic prognostic scoring system
|
HAEMATOLOGICA |
Artículo | 2012 |
Comparación de dos estrategias iniciales de movilización de progenitores hematopoyéticos de sangre periférica para trasplante autogénico en pacientes con linfomas e infección por el virus de la inmunodeficiencia humana
|
MEDICINA CLINICA |
Resumen congreso | 2012 |
Impact of V617F mutation in the management of thrombotic risk in patients with essential thrombocytemia
|
HAEMATOLOGICA |
Resumen congreso | 2012 |
Increased Gene Expression Involved in Angiogenesis, Metabolism and Cell Proliferation in Acute Myeloid Leukemia and myelodysplastic Syndromes Correlates with Adverse Clinical and Biological Features
|
BLOOD |
Artículo | 2012 |
Intra-Arterial Bone Marrow Mononuclear Cells in Ischemic Stroke A Pilot Clinical Trial
|
STROKE |
Artículo | 2012 |
Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2012 |
Patterns of Infection in Patients with Myeloid Malignancies Receiving 5-Azacytidine: identification of Candidates for Antifungal Prophylaxis
|
BLOOD |
Resumen congreso | 2012 |
To freeze or not to freeze haematopoietic stem cells prior to allogeneic transplantation
|
BONE MARROW TRANSPLANTATION |
Artículo | 2012 |
Universal antifungal therapy is not needed in persistent febrile neutropenia: a tailored diagnostic and therapeutic approach
|
HAEMATOLOGICA |
Resumen congreso | 2011 |
-52G/A Gene Variant in the beta-Defensin-1 (DEBF1) Influences the Development of Severe Acute Graft Versus Host Disease (aGvHD) After Allogeneic Stem Cell Transplantation (Allo-SCT). Functional Association of This Variant with a Low Anti- Inflammatory Response
|
BLOOD |
Resumen congreso | 2011 |
A Recessive Gene Variant in TGFBI in the Donor Influences the Acute Graft Versus Host Disease Development and Impacts in the Outcome After Allogeneic Stem Cell Transplantation (Allo-SCT)
|
BLOOD |
Resumen congreso | 2011 |
G to C Transition At Position-173 of MIF Gene Associates with Poor Survival in Acute Myeloid Leukemia Patients and After Allogeneic Stem Cell Transplantation (Allo-SCT)
|
BLOOD |
Artículo | 2011 |
Impact of constitutional polymorphisms in VCAM1 and CD44 on CD34(+) cell collection yield after administration of granulocyte colony-stimulating factor to healthy donors
|
HAEMATOLOGICA |
Artículo | 2011 |
Influence of glutathione S-transferase T1 donor/recipient mismatch and anti-GSTT1 antibodies in hepatic graft-versus-host-disease
|
IMMUNOLOGY LETTERS |
Resumen congreso | 2011 |
Outcome of pandemic H1N1 infections in haematopoietic stem cell transplant recipients
|
BONE MARROW TRANSPLANTATION |
Artículo | 2011 |
Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients
|
HAEMATOLOGICA |
Resumen congreso | 2011 |
Outcome of Second Allogeneic SCT Following Relapse of Hematological Malignancies After a First Allogeneic SCT
|
BLOOD |
Artículo | 2011 |
Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study
|
CLINICAL TRANSPLANTATION |
Resumen congreso | 2011 |
Prognostic Factors for Survival and Progression to Acute Myeloid Leukemia in Patients with Lower-Risk Myelodysplastic Syndromes. A New Scoring System
|
BLOOD |
Artículo | 2011 |
Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients
|
CLINICAL TRANSPLANTATION |
Resumen congreso | 2011 |
The Genotype in the Donor and Recipient for the Polymorphim-174 G/C of the IL-6 Influences the Outcome of HLA-Identical Related Stem Cell Transplantation
|
BLOOD |
Resumen congreso | 2011 |
The presence of allele G in the donor for the polymorphism A7488G of the IL-17 gene improves relapse rate and survival after HLA-identical related stem cell transplantation
|
BONE MARROW TRANSPLANTATION |
Artículo | 2011 |
Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients
|
ANTIVIRAL THERAPY |
Capítulo | 2010 |
Autotrasplante de progenitores hematopoyéticos en pacientes pediátricos diagnosticados de Sarcoma de Ewing óseo: Indicaciones y resultados
|
Actualizaciones en trasplantes 2010 |
Resumen congreso | 2010 |
BCR-ABL SEQUENCING AND MUTATIONAL STATUS IN CHRONIC MYELOID LEUKEMIA: DESCRIPTION OF ATYPICAL MUTATIONS AND RELATIONSHIP WITH RESPONSE TO IMATINIB AS A PRELIMINARY ANALYSIS OF A SINGLE CENTER STUDY
|
HAEMATOLOGICA |
Artículo | 2010 |
Clinical Utility of Real-Time Polymerase Chain Reaction to Quantify Cytomegalovirus Replication in Allogeneic Stem Cell Transplant Recipients With Different Prevention Strategies
|
TRANSPLANTATION PROCEEDINGS |
Resumen congreso | 2010 |
Comparison between lymphoglobulin- and thymoglobulin-based immunosuppressive therapy as first-line treatment for patients with aplastic anaemia
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2010 |
Constitutional variability in genes involved in innate immunity (IRF-3, HAMP, PTX3) and in cell proliferation (ATBF1 and NFAT5) influences disease free survival after allogeneic stem cell transplantation
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2010 |
CONSTITUTIONAL VARIABILITY IN GENES INVOLVED IN INNATE IMMUNITY AND IN CELL PROLIFERATION INFLUENCES DISEASE FREE SURVIVAL AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
|
HAEMATOLOGICA |
Resumen congreso | 2010 |
Cytomegalovirus Specific Immunity Protects From Cytomegalovirus Replication After Hematopoietic Stem Cell Transplantation
|
BLOOD |
Artículo | 2010 |
Differences in cytomegalovirus plasma viral loads measured in allogeneic hematopoietic stem cell transplant recipients using two commercial real-time PCR assays
|
JOURNAL OF CLINICAL VIROLOGY |
Resumen congreso | 2010 |
Differences in cytomegalovirus replication quantified by quantitative PCR and antigenemia pp-65 after allogeneic stem cell transplantation with different prevention strategies
|
BONE MARROW TRANSPLANTATION |
Artículo | 2010 |
Differences in Cytomegalovirus Replication Quantified Using Quantitative Polymerase Chain Reaction and Antigenemia After Allogeneic Stem Cell Transplantation
|
TRANSPLANTATION PROCEEDINGS |
Resumen congreso | 2010 |
Effect of glutathione S-transferase T1 mismatch in hepatic graft versus host disease after allogenic hemopoietic stem cell transplantation
|
TISSUE ANTIGENS |
Capítulo | 2010 |
El Programa de trasplante de progenitores hematoyéticos del Hospital Universitario Virgen del Rocío en el contexto español. Año 2009
|
Actualizaciones en trasplantes 2010 |
Artículo | 2010 |
Empirical antifungal therapy in selected patients with persistent febrile neutropenia
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2010 |
Genetic mismatch in GSTT1 is associated with hepatic acute graft-versus-host disease in allogeneic stem cell transplantation
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2010 |
Genetic Variability In the Transcriptional Factor EP300 Strongly Influences the Clinical Outcome of Allogeneic Stem Cell Transplantation (Allo-SCT)
|
BLOOD |
Letter | 2010 |
Glutathione S-transferase T1 is a potential new target for the hepatic component of graft vs host disease after HSCT
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2010 |
Glutathione S-Transferase T1 Mismatch and Presence of Anti-GSTT1 Antibodies In Hepatic Gvhd
|
BLOOD |
Resumen congreso | 2010 |
How organizational pre-transplant measures may improve clinical outcomes in haemopoietic stem cell transplantation
|
BONE MARROW TRANSPLANTATION |
Ponencia | 2010 |
Indication of empirical antifungal therapy in selected patients with persistent febrile neutropenia according to clinical criteria and risk profile
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2010 |
Influenza A (H1N1) Virus Infection in Hematologic patients In The South And West Of Spain
|
BLOOD |
Resumen congreso | 2010 |
Long-term follow-up of autologous stem cell transplant in AIDS-related Lymphoma patients. Results of Spanish Cooperative Registry GELTAMO/GESIDA
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2010 |
Minimal residual disease post-consolidation therapy affects outcome after stem cell transplantation in acute myeloid leukaemia
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2010 |
MOBILIZATION OF PERIPHERAL BLOOD STEM CELLS (PBSC) FOR AUTOLOGOUS STEM CELLTRANSPLANTATION (ASCT) IN PATIENTS WITH LYMPHOMA AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION
|
HAEMATOLOGICA |
Resumen congreso | 2010 |
Pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation guided by quantitative real time-PCR
|
BONE MARROW TRANSPLANTATION |
Artículo | 2010 |
Role of Second Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Hematologic Malignancies
|
TRANSPLANTATION PROCEEDINGS |
Capítulo | 2010 |
Sistematización de la etapa pre-trasplante hematopoyético como herramienta de mejora de los resultados clínicos
|
Actualizaciones en trasplantes 2010 |
Resumen congreso | 2010 |
The Genotype of the Donor for the Polymorphism A7488G of the IL-17 Gene Influences relapse and survival After HLA-Identical Related Stem Cell Transplantation.
|
BLOOD |
Artículo | 2010 |
Unrelated Transplantation for Poor-Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Outcome Analysis and Study of the Impact of Hematopoietic Graft Source
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
Resumen congreso | 2010 |
VCAM1 RS1041163 POLYMORPHISM INFLUENCES G-CSF MOBILIZATION OF CD34+CELLS
|
HAEMATOLOGICA |
Resumen congreso | 2009 |
Association of CXCL12, VCAM1 and CD34 gene polymorphisms with peripheral blood progenitor cell mobilisation in healthy donors
|
BONE MARROW TRANSPLANTATION |
Artículo | 2009 |
Autologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma
|
JOURNAL OF CLINICAL ONCOLOGY |
Corrección | 2009 |
Autologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma (vol 27, pg 2192, 2009)
|
JOURNAL OF CLINICAL ONCOLOGY |
Resumen congreso | 2009 |
Catheter-related infections in tunnelled central venous devices in haematologic malignancies and haematopoietic stem cell transplantation patients. A single-centre experience
|
BONE MARROW TRANSPLANTATION |
Artículo | 2009 |
Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation
|
BLOOD |
Resumen congreso | 2009 |
COMPARISON BETWEEN LYMPHOGLOBULINE- AND THYMOGLOBULINE-BASED IMMUNOSUPPRESSIVE THERAPY AS FIRST-LINE TREATMENT FOR PATIENTS WITH APLASTIC ANEMIA
|
HAEMATOLOGICA |
Resumen congreso | 2009 |
Comparison Between Lymphoglobuline- and Thymoglobuline-Based Immunosuppressive Therapy as First-Line Treatment for Patients with Aplastic Anemia.
|
BLOOD |
Resumen congreso | 2009 |
CXCL12 RS1801157 POLIMORPHISM IS ASSOCIATED WITH DECREASED MRNA CXCL12 EXPRESSION AND HIGHER HEMOPOIETIC PROGENITOR CELL MOBILIZATION
|
HAEMATOLOGICA |
Resumen congreso | 2009 |
Donor's Genetic Variability in NFAT5 and ATBF1, Transcriptional Factors Involved in Cellular Growth and Proliferation, Are Prognostic Factors for Disease Free Survival After Allogeneic Stem Cell Transplantation (Allo-SCT)
|
BLOOD |
Capítulo | 2009 |
Evaluación de la etapa pre-trasplante hematopoyético en pacientes con leucemia aguda.
|
Actualizaciones en trasplantes 2009 |
Capítulo | 2009 |
Evaluación de la infección por citomegalovirus tras el trasplante
|
Actualizaciones en trasplantes 2009 |
Resumen congreso | 2009 |
Hickman catheter-associated infections after haematopoietic stem cell transplantation and their relationship with period elapsing from catheter implantation to transplantation
|
BONE MARROW TRANSPLANTATION |
Capítulo | 2009 |
Infecciones relacionadas con catéteres venosos centrales permanentes en el Trasplante de Progenitores Hematopoyéticos y hemopatías malignas. Estudio descriptivo
|
Actualizaciones en trasplantes 2009 |
Artículo | 2009 |
Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study
|
HAEMATOLOGICA |
Resumen congreso | 2009 |
Long-Term Follow-up of HCV Infected Stem Cell Transplant Patients and Effects of Antiviral Therapy.
|
BLOOD |
Resumen congreso | 2009 |
Low-Intensity Fludarabine, Cyclophosphamyde, Rituximab (FCR) as Front-Line Treatment for Follicular Lymphoma. Efficacy and Toxicity Profile of the Oral Versus Intravenous Administration
|
BLOOD |
Resumen congreso | 2009 |
PO-065 Valor pronóstico de la enfermedad mínima residual previa al trasplante de progenitores hemopoyéticos en pacientes con leucemia mieloide aguda
|
HAEMATOLOGICA |
Resumen congreso | 2009 |
Predictive factors for relapse in adult patients with high-risk acute lymphoblastic leukaemia submitted to an unrelated haematopoietic progenitor transplant
|
BONE MARROW TRANSPLANTATION |
Capítulo | 2009 |
Programa de trasplante de progenitores hematopoyéticos de los HH UU Virgen del ROCÍO en 2008
|
Actualizaciones en trasplantes 2009 |
Resumen congreso | 2009 |
Reasons why acute leukaemia patients with established indication for stem cell transplantation do not finally undergo the procedure and its clinical consequences
|
BONE MARROW TRANSPLANTATION |
Capítulo | 2009 |
Replicación viral de CMV medida mediante PCR a tiempo real y antigenemia pp-65 tras el Trasplante Hematopoyético Alogénico (ALO-TPH)
|
Actualizaciones en trasplantes 2009 |
Resumen congreso | 2009 |
Results of reduced-intensity conditioning stem cell transplantation with intensified fludarabine-based regimen for advanced lymphoid malignancies
|
BONE MARROW TRANSPLANTATION |
Artículo | 2009 |
Risk score for outcome after allogeneic hematopoietic stem cell transplantation a retrospective analysis
|
CANCER |
Capítulo | 2009 |
Trasplante alogénico de progenitores hemopoyéticos con acondicionamiento de intensidad reducida en pacientes con neoplasias linfoides. Nuestra experiencia
|
Actualizaciones en trasplantes 2009 |
Editorial | 2008 |
Coste-efectividad del tratamiento antifúngico empírico de pacientes hematológicos con alto riesgo de infección fúngica invasora
|
FARMACIA HOSPITALARIA |
Artículo | 2008 |
Evaluación de la reactivación de citomegalovirus tras el trasplante
|
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY |
Artículo | 2008 |
Evaluation of the Pretransplantation Phase of the Hemopoietic Stem Cell Program in a Tertiary Hospital
|
TRANSPLANTATION PROCEEDINGS |
Ponencia | 2008 |
Gestión electrónica del programa de trasplante hemopoyético ¿Por qué algunos candidatos no llegan a trasplantarse?
|
Eliminando las barreras del conocimiento: XII Encuento Internacional de Investigación en Enfermería conjuntamente con 6º Coloquio Bianual Joanna Briggs Córdoba, Spain 12-15 Noviembre 2008 |
Artículo | 2008 |
High Rate of Long-Term Survival for High-Risk Lymphoma Patients Treated With Hematopoietic Stem Cell Transplantation as Consolidation or Salvage Therapy
|
TRANSPLANTATION PROCEEDINGS |
Resumen congreso | 2008 |
Long-term follow-up of HCV infected patients; Updated results of the EBMT prospective study
|
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES |
Artículo | 2008 |
Preemptive Therapy for Cytomegalovirus Disease in Allogeneic Stem Cell Transplant Recipients
|
TRANSPLANTATION PROCEEDINGS |
Resumen congreso | 2008 |
The efficacy of a single dose pegfilgrastim following myeloablative chemotherapy for stem cell mobilisation in patients with solid tumours and lymphomas
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2008 |
The role of reduced-intensity allogeneic stem cell transplantation in patients with advanced acute myeloid leukaemia and myelodysplastic syndromes
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2008 |
UNRELATED TRANSPLANTS FOR POOR PROGNOSIS ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: LONG-TERM COMPARATIVE ANALYSIS BASED ON THE HEMATOPOIETIC PROGENITOR SOURCE
|
HAEMATOLOGICA |
Resumen congreso | 2008 |
Unrelated Transplants for Poor Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Comparative Analysis Based on the Hematopoietic Progenitor Source.
|
BLOOD |
Resumen congreso | 2007 |
Autologous stem cell transplantation (ASCT) in HIV associated lymphoma (HIV-Ly) patients: An updated analysis of the EBMT lymphoma working party (EBMT-LWP) experience.
|
BLOOD |
Resumen congreso | 2007 |
Comparable survival between HIV plus and HIV-Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL) patients undergoing an autologous peripheral blood stem cell transplantation (ASCT). A retrospective analysis of the EBMT lymphoma working party
|
BLOOD |
Resumen congreso | 2007 |
Comparison of PCR-Reverse Line Blot analysis and traditional culture of dermatophytes in clinical samples
|
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS |
Resumen congreso | 2007 |
Comprehensive view of the haemopoietic stem cell program: The pre-transplant phase
|
HAEMATOLOGICA |
Artículo | 2007 |
CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors
|
BLOOD |
Capítulo | 2007 |
Estudio descriptivo de las complicaciones infecciosas de 60 receptores de trasplante alogénico de progenitores hematopoyéticos consecutivos
|
Actualizaciones en trasplantes 2007 |
Capítulo | 2007 |
Evaluación del uso de antifúngicos en receptores de trasplantes de progenitores hematopoyéticos y otros pacientes hematológicos
|
Actualizaciones en trasplantes 2007 |
Resumen congreso | 2007 |
Incidence of neutropenia and hypogammaglobulinemia and correlation with the infections rate in indolent non-Hodgkin lymphoma (NHL) receiving rituximab maintenance
|
BLOOD |
Resumen congreso | 2007 |
Risk factors for bacteraemia caused by extended-spectrum beta-lactamase producing-Escherichia coli in hospitalized haematological patients
|
HAEMATOLOGICA |
Artículo | 2007 |
Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease
|
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
Resumen congreso | 2007 |
The role of allogeneic stem cell transplantation with reduced-intensity conditioning in patients with chemoresistant malignancies
|
BONE MARROW TRANSPLANTATION |
Capítulo | 2007 |
Trasplante de progenitores hematopoyéticos de intensidad reducida enpacientes resistentes a terapias convencionales
|
Actualizaciones en trasplantes 2007 |
Capítulo | 2007 |
Trasplantes de progenitores hematopoyéticos de los HH UU Virgen del Rocío en 2006
|
Actualizaciones en trasplantes 2007 |
Resumen congreso | 2006 |
Autologous stem cell transplantation (ASCT) in HIV associated lymphoma (HIV-Ly) patients: The EBMT lymphoma working party (EBMT-LWP) experience.
|
BLOOD |
Letter | 2006 |
Clinical outcome after sex-mismatched allogeneic stem cell transplantation from human lymphocyte antigen-identical sibling donors: influence of stem cell source
|
LEUKEMIA |
Resumen congreso | 2006 |
Comparative study of autologous stem cell transplant (ASCT) in HIV-1 positive (HIV plus ) on haart and HIV-1 negative (HIV-) non Hodgkin lymphoma (NHL) patients.
|
BLOOD |
Resumen congreso | 2006 |
Epidemiology of cytomegalovirus in allogeneic haematopoietic stem cell transplant recipients
|
BONE MARROW TRANSPLANTATION |
Artículo | 2006 |
Evaluation of readmissions in hematopoietic stem cell transplant recipients
|
TRANSPLANTATION PROCEEDINGS |
Revisión | 2006 |
Hematopoietic stem cell transplantation in systemic autoimmune diseases. State of the art
|
REUMATOLOGIA CLINICA |
Resumen congreso | 2006 |
Readmissions evaluation in allogeneic haematopoietic stem cell transplant recipients
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2005 |
Cyclosporine and methotrexate immunosuppression based regimen after non-myeloablative haematopoietic stem cell transplantation. Single-centre experience
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2005 |
Does highly active anti-retroviral therapy (HAART) delay myeloid engraftment after autologous stem cell transplant (ASCT) in HIV associated lymphoma (HIV plus Ly) patients?
|
BLOOD |
Artículo | 2005 |
Hemopoietic stem cell transplantation in childhood: Reduction in mortality and improvement of survival over the years
|
TRANSPLANTATION PROCEEDINGS |
Resumen congreso | 2005 |
Rapamycine (Sirolimus) as salvage therapy for chronic graft-versus-host disease
|
BONE MARROW TRANSPLANTATION |
Revisión | 2005 |
Tratamiento antifúngico empírico en pacientes seleccionados con fiebre persistente y neutropenia Empirical antifungal therapy in selected patients with persistent fever and neutropenia
|
Enfermedades infecciosas y microbiología clínica |
Artículo | 2004 |
Autologous Hemopoietic Stem Cell Transplantation in Severe Rheumatoid Arthritis: A Report from the EBMT and ABMTR
|
JOURNAL OF RHEUMATOLOGY |
Resumen congreso | 2004 |
Efficacy and safety of fludarabine/cyclophosphamide (FC) as front-line treatment of CLL. Final results of a phase II clinical trial in a single center.
|
BLOOD |
Artículo | 2004 |
Haematopoetic stem cell transplantation for refractory autoimmune cytopenia
|
BRITISH JOURNAL OF HAEMATOLOGY |
Artículo | 2004 |
HLA-DPB1 mismatch in HLA-A-B-DRB1 identical sibling donor stem cell transplantation and acute graft-versus-host disease
|
TRANSPLANTATION |
Resumen congreso | 2004 |
HLA-DPB1 mismatch is associated with acute GvHD after HLA-identical sibling donor stem cell transplantation
|
BONE MARROW TRANSPLANTATION |
Letter | 2004 |
Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation
|
LEUKEMIA |
Corrección | 2004 |
Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation (vol 18, pg 1031, 2004)
|
LEUKEMIA |
Artículo | 2003 |
Autotrasplante de progenitores hematopoyéticos en el tratamiento de las enfermedades autoinmunes. Experiencia internacional y española
|
Revista Española de Reumatología |
Resumen congreso | 2003 |
Efficacy and safety of Fludarabine/Cyclophosphamide (FC) as front-line treatment of CLL. Preliminary results of a phase II clinical trial.
|
BLOOD |
Artículo | 2003 |
Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation
|
HAEMATOLOGICA |
Resumen congreso | 2003 |
Hemopoietic stem cell transplantation in childhood: improved survival over the years and reduction of transplant-related mortality in the autologous setting
|
BONE MARROW TRANSPLANTATION |
Artículo | 2003 |
Hemopoietic stem cell transplantation in refractory rheumatoid arthritis is not a contraindication for reconstructive surgery
|
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
Artículo | 2003 |
Phase I/II trials of autologous peripheral blood stem cell transplantation in autoimmune diseases resistant to conventional therapy: Preliminary results from the Spanish experience
|
TRANSPLANTATION PROCEEDINGS |
Artículo | 2003 |
Positive selection for CD34(+) reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation
|
EXPERIMENTAL HEMATOLOGY |
Editorial | 2003 |
Trasplante de progenitores hemopoyéticos e inducción de tolerancia inmunológica en las enfermedades autoinmunes
|
FARMACIA HOSPITALARIA |
Artículo | 2002 |
Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors
|
TRANSFUSION |
Resumen congreso | 2002 |
Chronic graft versus host disease after allogeneic transplantation of CD34+selected cells from peripheral blood from HLA-identical siblings.
|
BLOOD |
Ponencia | 2002 |
Hematopoietic stem cell transplantation in patients or from donors with hepatitis B or C virus infection: Review and recommendations
|
MEDICINA CLINICA |
Editorial | 2002 |
Immunosuppression and hematopoietic stem cell transplantation for autoimmune diseases
|
MEDICINA CLINICA |
Artículo | 2002 |
Inmunoablación y trasplante de progenitores hematopoyéticos en las enfermedades autoinmunes
|
MEDICINA CLINICA |
Resumen congreso | 2002 |
Phase I/II trials of autologous peripheral blood stem cell transplantation (ASCT) in autoimmune diseases (AID) resistant to conventional therapy: preliminary results of the Spanish experience
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2002 |
Positive selection for CD34+reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.
|
BLOOD |
Resumen congreso | 2002 |
Risk factors for acute graft-versus-host disease in patients transplanted with CD34+selected blood cells from HLA-identical siblings
|
BONE MARROW TRANSPLANTATION |
Artículo | 2002 |
Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34(+) selected blood cells from HLA-identical siblings
|
BLOOD |
Artículo | 2002 |
Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields
|
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH |
Resumen congreso | 2001 |
Allogeneic peripheral blood stem cell transplantation (allo-PBT): results of 327 patients from the Spanish registry.
|
BONE MARROW TRANSPLANTATION |
Artículo | 2001 |
Allogeneic transplantation of CD34(+)-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation
|
BONE MARROW TRANSPLANTATION |
Letter | 2001 |
Autologous stem cell transplantation in a patient with rheumatoid arthritis [4]
|
MEDICINA CLINICA |
Artículo | 2001 |
Autotrasplante de progenitores hematopoyéticos en una paciente con artritis reumatoide
|
MEDICINA CLINICA |
Artículo | 2001 |
Donor age-related differences in PBPC mobilization with rHuG-CSF
|
TRANSFUSION |
Artículo | 2001 |
Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies
|
BRITISH JOURNAL OF HAEMATOLOGY |
Artículo | 2001 |
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
|
ANNALS OF THE RHEUMATIC DISEASES |
Resumen congreso | 2001 |
Plasma levels of t-PA Ag and D-dimer predict development of veno-occlussive disease of the liver (VOD) in patients undergoing allogeneic stem cell transplant.
|
BLOOD |
Artículo | 2001 |
The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings
|
BLOOD |
Resumen congreso | 2001 |
Variables affecting the collection of a CD34+cell dose > 4 x106/kg in healthy donors with one apheresis
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 2000 |
Analysis of factors associated with a low peripheral blood progenitor cell (PBPC) collection in normal donors.
|
BLOOD |
Resumen congreso | 2000 |
Predictive factors for graft versus host disease after allogeneic transplantation of CD34+selected cells from peripheral blood (allo-PBT/CD34+) from HLA-identical siblings.
|
BLOOD |
Resumen congreso | 2000 |
The number of donor CD3+cells is the most important factor for graft failure after allogeneic transplantation of CD34+selected cells from peripheral blood (allo-PBT/CD34+) from HLA-identical siblings.
|
BLOOD |
Ponencia | 2000 |
The number of donor CD34+ and CD3+ cells is the most important factor for disease free survival after allogeneic transplantation of CD34+ selected cells from peripheral blood (allo-PBT/CD34+) from HLA-identical siblings
|
Hematology and Cell Therapy |
Resumen congreso | 2000 |
The number of donor CD34+and CD3+cells is the most important factor for disease free survival (DFS) after allogeneic transplantation of CD34+selected cells from peripheral blood (allo-PBT/CD34+) from HLA-identical siblings.
|
BLOOD |
Artículo | 2000 |
Trasplante autólogo de progenitores hematopoyéticos en las enfermedades autoinmunes
|
Revista Española de Reumatología |
Artículo | 1999 |
Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 1999 |
Allogeneic vs autologous haemopoietic stem cell transplant (HSCT) in acute leukaemia (AL).
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 1999 |
Comparative study of filgrastim and lenograstim for peripheral blood stem cell mobilization in healthy donors
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 1999 |
Donor age related differences in peripheral blood stem mobilization with recombinant human granulocyte-colony stimulating factor (rhG-CSF).
|
BLOOD |
Resumen congreso | 1999 |
Evidence of graft-versus-tumor (GVT) effect in 136 patients with advanced hematologic malignancies receiving unmanipulated peripheral blood stem cell allografts (allo-PSCT): The Spanish experience.
|
BLOOD |
Resumen congreso | 1999 |
Hemostatic and endothelial dammage markers in allogenic and autologous bone marrow transplantation
|
THROMBOSIS AND HAEMOSTASIS |
Artículo | 1999 |
Prospective, comparative study of different amino acid and lipid solutions in the parenteral nutrition of patients subjected to a bone marrow transplantation
|
NUTRICION HOSPITALARIA |
Letter | 1999 |
Reactivation of HBV following allogeneic bone marrow transplantation: new approaches
|
Revista Española de Enfermedades Digestivas |
Letter | 1999 |
Reactivation of HBV following allogeneic bone marrow transplantation: new outlook (the hepatitis B virus and the bone marrow transplant)
|
Revista Española de Enfermedades Digestivas |
Revisión | 1999 |
Trasplante autólogo de progenitores hematopoyéticos en pacientes con artritis reumatoide resistentes al tratamiento convencional
|
Revista Española de Reumatología |
Resumen congreso | 1998 |
Allogeneic peripheral blood progenitor cell transplantation (allo-PBT) in 64 patients with advanced hematologic malignancies.
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 1998 |
Allogeneic peripheral blood progenitor cells transplantation (allo-PBT) in 64 patients with advanced hematologic malignancies.
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 1998 |
Early infections in 163 consecutive autologous hemopoietic progenitor cell transplants.
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 1998 |
Effects of granulocyte-colony stimulating factor in normal donors. Results of the Spanish National Donor Registry.
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 1998 |
Transplantation with peripheral blood stem cells from unrelated donor in chronic myelocytic leukaemia.
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 1997 |
Allogeneic peripheral blood progenitor cells transplantation (allo-PBT) for patients with advanced hematologic malignancies.
|
BLOOD |
Artículo | 1997 |
Trasplante alogénico de progenitores hemopoyéticos de sangre periférica no manipulados: Experiencia española de 79 casos
|
SANGRE |
Artículo | 1995 |
Reversal of severe hepatic veno-occlusive disease by combined plasma exchange and rt-PA treatment
|
BONE MARROW TRANSPLANTATION |
Nota | 1995 |
REVERSAL OF SEVERE HEPATIC VENOOCCLUSIVE DISEASE BY COMBINED PLASMA-EXCHANGE AND RT-PA TREATMENT
|
BONE MARROW TRANSPLANTATION |
Artículo | 1993 |
Generation of LAK cells in vitro in patients with acute leukemia
|
LEUKEMIA |
Resumen congreso | 1993 |
HIGH FLUORESCENCE RETICULOCYTES INCREASE IN PERIPHERAL-BLOOD IS THE FIRST SIGN OF CIRCULATING STEM-CELLS AFTER APLASIA INDUCED CHEMOTHERAPY
|
EXPERIMENTAL HEMATOLOGY |
Artículo | 1992 |
A fully automated method for mononuclear bone marrow cell concentration
|
Journal of Clinical Apheresis |
Artículo | 1990 |
PERIPHERAL BLOOD STEM CELL COLLECTION: COMPARISON OF TWO PROTOCOLS
|
BONE MARROW TRANSPLANTATION |
Artículo | 1990 |
PERIPHERAL-BLOOD STEM-CELL COLLECTION - COMPARISON OF 2 PROTOCOLS
|
BONE MARROW TRANSPLANTATION |
Letter | 1990 |
Thrombotic thrombocytopenic purpura in a patient with the acquired immunodeficiency syndrome
|
REVISTA CLINICA ESPANOLA |